type 1 diabetes mellitus

Search with Google Search with Bing
Information
Disease name
type 1 diabetes mellitus
Disease ID
DOID:9744
Description
"A diabetes mellitus that is characterized by destruction of pancreatic beta cells resulting in absent or extremely low insulin production." [url:http\://en.wikipedia.org/wiki/Diabetes, url:http\://en.wikipedia.org/wiki/Diabetes_mellitus_type_1]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
NCT ID Status Phase Summary Start date Completion date
NCT00679042 Active, not recruiting Phase 3 Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol September 5, 2007 June 14, 2026
NCT05574335 Active, not recruiting Phase 1/Phase 2 Siplizumab in T1DM April 26, 2023 December 31, 2027
NCT05018416 Active, not recruiting Phase 2 Study of Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007) July 27, 2021 September 22, 2026
NCT04141761 Active, not recruiting Phase 2 Probiotics in Newly Diagnosed T1D April 1, 2019 June 30, 2025
NCT04129528 Active, not recruiting Phase 2 Study of Safety and Efficacy of CFZ533 in Type 1 Diabetes Pediatric and Young Adult Subjects November 8, 2019 May 31, 2024
NCT03734107 Active, not recruiting N/A Improving Health Communication During the Transition From Pediatric to Adult Diabetes Care November 6, 2018 December 15, 2024
NCT03475108 Active, not recruiting N/A Integrating Community Health Workers Into the Care of Children With Type 1 Diabetes April 19, 2018 December 2024
NCT00360893 Active, not recruiting Epidemiology of Diabetes Interventions and Complications (EDIC) April 1994 June 2027
NCT03917238 Active, not recruiting N/A Beta Cell Imaging During and Shortly After the Honeymoon Phase of T1D October 11, 2019 December 25, 2026
NCT03914547 Active, not recruiting N/A Home Video-based Telemedicine to Reduce Hypoglycemia Fear in Parents of Young Children October 15, 2019 March 31, 2025
NCT04429503 Active, not recruiting Phase 2/Phase 3 Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease June 29, 2020 June 29, 2024
NCT02213003 Active, not recruiting Phase 1/Phase 2 Allogeneic Islet Cells Transplanted Onto the Omentum September 2014 May 2026
NCT00279318 Active, not recruiting TEDDY - The Environmental Determinants of Diabetes in the Young September 2004 September 2025
NCT01909245 Active, not recruiting Phase 2 Islet Cell Transplant for Type 1 Diabetes October 16, 2013 October 16, 2025
NCT03895996 Active, not recruiting Phase 1/Phase 2 Safety, Tolerability and Potential Efficacy of AVT001 in Patients With Type 1 Diabetes June 20, 2019 December 2023
NCT03791567 Approved for marketing Islet Transplantation in Type I Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol
NCT01606475 Available Islet Transplant for Type 1 or Surgical Diabetes
NCT00321256 Completed Phase 1/Phase 2 Human Islet Transplantation in Brittle Type 1 Diabetes Mellitus. The GRAGIL 2 Study. July 2003 July 2007
NCT00324207 Completed Molecular Quantification of Insulin mRNA February 2006 January 2009
NCT00324584 Completed Phase 3 Web-Based Follow-Up Using Cellular Phone in Type 1 Diabetic Patients Under Insulin Pump Therapy : The PumpNet Study April 2003 September 2004
NCT00327210 Completed N/A Feasibility and Efficacy of Delivering Blood Glucose Awareness Training Over the Internet May 2005 July 2009
NCT00330954 Completed Gene Expression Profiling in Type 1 Diabetes June 2006 April 2008
NCT00333554 Completed N/A Nutritional Intervention to Prevent Diabetes June 2006 April 2013
NCT00358059 Completed Phase 3 Behavior Therapy for Families of Diabetic Adolescents October 2000 January 2006
NCT00360061 Completed N/A CBT in Adolescents With Type 1 Diabetes September 2001 June 2005
NCT00360815 Completed N/A Diabetes Control and Complications Trial (DCCT) August 1983 April 1993
NCT00360984 Completed Phase 4 Prevention of Severe Hypoglycemia in Type 1 Diabetes May 2003 September 2004
NCT00371800 Completed Phase 2/Phase 3 The Effect of Cinnamon on HbA1c Among Adolescents With Type I Diabetes October 2005 May 2006
NCT00378508 Completed Phase 2 Anti-CD3 mAb Treatment of Recent Onset Type 1 Diabetes September 2006 August 2013
NCT00385697 Completed Phase 2/Phase 3 The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus October 2006 August 2011
NCT00434811 Completed Phase 3 Islet Transplantation in Type 1 Diabetes October 2006 May 2014
NCT00442767 Completed Phase 4 Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes Mellitus February 2007 February 2009
NCT00449891 Completed Neuropsychological and Neuroanatomical Studies of Young Children With and Without Type 1 Diabetes Mellitus January 2007 March 2016
NCT00461331 Completed Phase 4 Comparison of Insulins Aspart and Lispro in Insulin Pumps October 2004 August 2008
NCT00464555 Completed Phase 2 Strategies to Improve Islet Survival December 2006 February 2014
NCT00468117 Completed Phase 3 Efficacy of Islet After Kidney Transplantation January 2007 July 5, 2017
NCT00468403 Completed Phase 2 LEA29Y (Belatacept) Emory Edmonton Protocol October 2008 April 2013
NCT00475345 Completed N/A Impact of Optimized Titration and Delivery of Bedtime Insulin on Prevention of Nocturnal Hypoglycemia August 2000 September 2001
NCT00476788 Completed N/A Fast Track CSII Using a Novel Device in Young Children With Newly Diagnosed T1DM April 2007 September 2009
NCT00477204 Completed Phase 2 Clinical Trial of Zocor (Simvastatin) and Vytorin (Ezetimibe/Simvastatin) in Adolescents With Type 1 Diabetes May 2007 August 2010
NCT00481598 Completed N/A Non Invasive Assessment of Liver Glycogen Kinetics and ATP Synthesis in Type1 Diabetics January 2006 September 2008
NCT00482443 Completed N/A Assessing the Effectiveness of Diabetes Interactive Diary (DID) in Diabetes Management March 2007 April 2008
NCT00497536 Completed Phase 4 Pharmacokinetics of IAsp Following CSII in Patients With T1DM July 2007 July 2008
NCT00505375 Completed Phase 2 Intravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes Mellitus February 2008 May 2012
NCT00521105 Completed N/A Assessment of an Alternative Model of Follow-up of Children and Adolescents With Type 1 Diabetes August 2005 November 2009
NCT00529399 Completed Phase 2 Effects of Recombinant Human Glutamic Acid Decarboxylase on the Progression of Type 1 Diabetes in New Onset Subjects February 2009 May 2012
NCT00542399 Completed Phase 4 Comparing the Metabolic Control of Once to Twice-daily Insulin Detemir Injections November 2007 March 2010
NCT00542724 Completed Phase 3 An Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIAject™ and Regular Human Insulin in Patients With Type 1 Diabetes Mellitus September 2006
NCT00545857 Completed Phase 1 Effect of Pioglitazone on the Course of New Onset Type 1 Diabetes Mellitus June 2002 May 2012
NCT00564395 Completed Phase 4 Detemir: Role in Type 1 Diabetes August 2007 May 2010
NCT00570102 Completed Phase 2 Nutritional Prevention Pilot Trial for Type 1 Diabetes February 1995 January 2008
NCT00596323 Completed Implantable Antenna Sensors for Continuous Glucose Monitoring June 2007 June 2008
NCT00607230 Completed Phase 1 Determination of Dosing and Frequency of BCG Administration to Alter T-Lymphocyte Profiles in Type I Diabetics November 2007 February 2011
NCT00622271 Completed N/A Intervention Groups for Adolescents With Type 1 Diabetes Mellitus February 2008 March 2010
NCT00639964 Completed N/A Exploration of the Lipid Metabolism During the Diabetic Pregnancies January 2008 December 2013
NCT00645840 Completed Phase 1/Phase 2 Anti-inflammatory Therapy With Anakinra in Newly Diagnosed Type 1 Diabetes March 2008 September 2009
NCT03676465 Completed N/A CloudConnect: Predictive And Retrospective Clinical Decision Support For Chronic Disease Management January 18, 2019 February 2, 2021
NCT00108004 Completed Phase 3 Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus April 2003 June 2005
NCT00130481 Completed N/A Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT) April 2005 April 2007
NCT00145379 Completed Phase 4 The Effect of Metformin in Overweight Patients With Dysregulated Type 1 Diabetes Mellitus March 2003 June 2006
NCT00212329 Completed T Cell Validation Study Using Blood Samples From Subjects With Recent Onset Type 1 Diabetes Mellitus September 2005 September 2007
NCT00213109 Completed Phase 3 Open Trial of Miglitol in Type 1 Diabetic Patients With Insulin Treatment
NCT00229658 Completed An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes September 2005 May 2008
NCT00265473 Completed Phase 1/Phase 2 MGA031, Sirolimus and Tacrolimus in Islet Transplantation November 2005 June 2010
NCT00276250 Completed Phase 2 Islet Transplantation Using Abatacept December 2005 December 2014
NCT00279305 Completed Phase 2 Rituximab in New Onset Type 1 Diabetes August 2005 November 2009
NCT00286624 Completed Phase 1/Phase 2 Anti-Thymocyte Globulin, Cyclosporine, and RAD in Islet Transplantation March 2003 August 2006
NCT00297583 Completed Phase 1 Insulin Glulisine in Type 1 Diabetes Mellitus April 2004
NCT00305344 Completed Phase 1/Phase 2 Umbilical Cord Blood Infusion to Treat Type 1 Diabetes April 2005 May 2011
NCT00313183 Completed Phase 2 A Study to Evaluate Symlin in Adolescent Subjects With Type 1 Diabetes Mellitus April 2006 August 2007
NCT00315133 Completed Phase 1/Phase 2 Safety and Efficacy Study of Autologous Stem Cell Transplantation for Early Onset Type I Diabetes Mellitus December 2003 December 2014
NCT00315627 Completed Phase 2 Steroid-free and Long-term Calcineurin-free Trial in Islet Cell Transplantation July 2005 January 2014
NCT00315952 Completed Phase 4 Study to Estimate the Effects of Inhaled Versus Intravenous (IV) Infusion of Human Insulin in Subjects With Type 1 Diabetes April 2006 December 2006
NCT03092310 Completed N/A Feasibility Evaluation of an Artificial Pancreas With Glucose Prediction Trust Index March 20, 2017 December 20, 2017
NCT03095651 Completed Phase 1 Multiple Ascending Dose Study of MK-5160 in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-5160-002) April 12, 2017 January 30, 2018
NCT03101865 Completed N/A The Artificial Pancreas in Very Young Children With T1D - Pilot (KidsAP01) August 8, 2017 May 11, 2018
NCT03107208 Completed Phase 4 Early Glargine (Lantus) in DKA Management in Children With Type 1 Diabetes July 21, 2017 March 13, 2021
NCT03128229 Completed Diabetic Kidney Alarm (DKA) Study June 1, 2017 December 13, 2019
NCT03147274 Completed N/A Group Education Curriculum for Older Teens With Type 1 Diabetes May 3, 2017 February 21, 2019
NCT03162926 Completed Phase 1 A Safety and Tolerability Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus July 5, 2017 February 15, 2018
NCT03168867 Completed N/A Effectiveness Trial of an E-Health Intervention To Support Diabetes Care in Minority Youth (3Ms) September 25, 2017 August 3, 2021
NCT03170544 Completed Phase 1 Single Ascending Dose Study of MK-1092 in Healthy Participants and in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-1092-001) August 16, 2017 November 8, 2018
NCT03176524 Completed Phase 1 A Trial to Investigate the Safety and the Pharmacokinetic, Pharmacodynamic Characteristics of Two BioChaperone® Glucagon Formulations Compared to Marketed GlucaGen® in Subjects With T1DM June 6, 2017 September 4, 2017
NCT03182842 Completed N/A FreeStyle Libre FGM During Summer Camp for Children With Type 1 Diabetes June 17, 2017 July 1, 2017
NCT03188757 Completed N/A The Influence of Acute Hyperglycaemia on Brain in T1D July 13, 2017 March 30, 2018
NCT03195257 Completed N/A Glucose-Dependent Insulinotropic Polypeptide - Effects on Markers of Bone Turnover in Patients With Type 1 Diabetes November 17, 2012 December 1, 2016
NCT03212950 Completed N/A Closed-Loop With Faster Aspart in Young Adults With Type 1 Diabetes July 10, 2017 November 1, 2017
NCT03214107 Completed N/A Carbohydrate-based Strategies to Prevent Exercise-induced Hypoglycemia August 3, 2017 August 2, 2019
NCT03214367 Completed Phase 3 A Study of LY900014 in Participants With Type 1 Diabetes July 17, 2017 August 22, 2019
NCT03222180 Completed N/A A Crowdsourced Social Media Portal for Parents of Very Young Children With Type 1 Diabetes February 15, 2018 March 31, 2020
NCT03228004 Completed Phase 1 Type 1 Diabetes Data Acquisition and Transfer Adherence Study July 26, 2017 April 8, 2019
NCT03240432 Completed N/A Wireless Innovation for Seniors With Diabetes Mellitus September 26, 2017 September 10, 2019
NCT03241212 Completed N/A Adolescent Self-Care and Knowledge Education in Diabetes--Improved by Texting September 12, 2017 December 14, 2018
NCT03263494 Completed Phase 3 CGM Intervention in Teens and Young Adults With Type 1 Diabetes (T1D) January 25, 2018 November 7, 2019
NCT03272269 Completed Phase 1 Study of IMCY-0098 in Patients With Recent Onset Type 1 Diabetes August 23, 2017 August 30, 2019
NCT03285386 Completed N/A Priming Exercise in Type 1 Diabetes January 1, 2018 December 1, 2018
NCT03293082 Completed Preschool CGM Use and Glucose Variability in Type 1 Diabetes September 30, 2017 September 30, 2017
NCT03307850 Completed N/A Impact of Non-glucose Signals on Glycemic Control in Patients With Type 1 Diabetes November 1, 2017 August 31, 2018
NCT03310944 Completed Phase 1 Comparison of Sotagliflozin Prototype Tablets With Reference Tablet in Healthy Subjects October 18, 2017 December 8, 2017
NCT03324438 Completed N/A Home Telemedicine to Optimize Health Outcomes in High-Risk Youth With Type 1 Diabetes November 1, 2017 September 30, 2021
NCT03328845 Completed Phase 4 Impact on the Oxidative Stress of the Different Analogues of Insulin in People With Type 1 Diabetes. (Ineox Study) January 20, 2017 November 20, 2021
NCT03333525 Completed N/A Does Protein and Fat Content of Meal Increase Glucose Concentrations September 10, 2013 February 20, 2014
NCT03354286 Completed N/A Supporting Parents of Young Children With Type 1 Diabetes in Closed-Loop System November 7, 2017 March 18, 2019
NCT03367351 Completed N/A Web-Based Intervention Designed to Educate and Improve Adherence Through Learning to Use Continuous Glucose Monitoring March 9, 2018 November 1, 2018
NCT03368586 Completed Accuracy, Satisfaction and Usability of a FGM System Among Children and Adolescents Attending a Diabetes Summer Camp July 2, 2016 July 30, 2017
NCT03369067 Completed N/A Artificial Pancreas and Remote Monitoring During a T1DM Youth Ski Camp December 18, 2017 April 15, 2018
NCT03394352 Completed N/A Exercise Activity-Based Bolus Decisions in Type 1 Diabetes January 17, 2018 May 11, 2018
NCT03397147 Completed N/A Pilot Sleep Intervention to Improve Diabetes Management in School-Aged Children July 5, 2018 July 9, 2019
NCT03400501 Completed Early Phase 1 Reducing the Risk of Metabolic Decompensation in Diabetic Adolescents by Supervised School Administration of Insulin October 1, 2017 June 7, 2021
NCT03428932 Completed N/A Glycemic Control and the Brain in Children With Type 1 Diabetes February 1, 2018 July 1, 2019
NCT03435198 Completed Biomarkers in Exhaled Breath of Glucose Fluctuation in Type 1 Diabetes March 1, 2018 August 30, 2018
NCT03436498 Completed Phase 1 Safety Assessment of SAR341402 and NovoLog® Used in Continuous Subcutaneous Insulin Infusion for Type 1 Diabetes Mellitus Patients May 10, 2018 October 6, 2018
NCT03436628 Completed N/A Using an mHealth App to Transition Care of Type-1 Diabetes From Parents to Teens March 1, 2018 December 31, 2019
NCT03439072 Completed Phase 3 G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes January 23, 2018 May 3, 2018
NCT03443713 Completed N/A Evaluation of Physician-based Decision Support July 18, 2018 May 8, 2019
NCT03451201 Completed N/A High-Intensity Exercise and Endothelial Function in Type 1 Diabetes(HIIT-T1D) January 2015 January 2017
NCT03452605 Completed N/A The Effect of Cocoa Flavanol on the BOLD Response and Cognitive Function in Type 1 Diabetes November 20, 2015 March 15, 2017
NCT03465878 Completed Phase 1 A Study of LY900014 in Participants With Type 1 Diabetes Mellitus March 26, 2018 November 14, 2019
NCT03478254 Completed Adherence to Guidelines VAccination in Type 1 DIabetes Mellitus Patients (AVADI-1). December 1, 2017 December 31, 2018
NCT03490773 Completed Type 1 Diabetes, Immunology, Genetics & Endogenous Insulin Production November 1, 2014 December 30, 2021
NCT03497260 Completed N/A Fructose in Exercising Individuals With Type 1 Diabetes Using Insulin Degludec January 4, 2019 September 8, 2019
NCT03504046 Completed Phase 2/Phase 3 Safety and Feasibility Evaluation of the APS APP February 28, 2018 September 4, 2018
NCT03506711 Completed N/A Isometric Handgrip Exercise -MRI in Children and Adolescents February 1, 2016 December 30, 2019
NCT03512236 Completed Phase 1 A Trial to Investigate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BioChaperone® Pramlintide Insulin in Patients With Type 1 Diabetes Mellitus April 25, 2018 February 14, 2019
NCT03528174 Completed N/A Single Hormone Closed Loop Study With PDT Sensor April 16, 2018 July 1, 2018
NCT03549104 Completed N/A A Cognitive Behavioral Therapy (CBT) Intervention to Reduce Fear of Hypoglycemia in Type 1 Diabetes January 14, 2019 June 30, 2021
NCT03556631 Completed Phase 4 Effect of Live Combined Bifidobacterium and Lactobacillus on Glycemic Control and Other Outcomes in Type 1 Diabetes September 1, 2020 October 30, 2021
NCT03557151 Completed N/A Transdisciplinary Versus Usual Care for Type1 Diabetes in Adolescence July 13, 2018 March 31, 2022
NCT03563313 Completed N/A The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas June 28, 2018 April 8, 2019
NCT03581968 Completed N/A Efficacy of Closed-Loop Strategy With and Without a Learning Component in Children and Adolescents With Type 1 Diabetes at a Diabetes Camp July 2, 2018 August 10, 2018
NCT03591354 Completed N/A The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas (DCLP3 Extension) January 17, 2019 March 9, 2020
NCT03600116 Completed Collection of Breath and Sweat to Identify Indicators of Hypoglycemia May 24, 2018 November 20, 2018
NCT03602963 Completed Comparison Between Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System and the FreeStyle Libre Flash Glucose Monitoring System July 9, 2018 March 30, 2019
NCT03610984 Completed Cohort Study of Patients With Type 1 Diabetes October 1, 2016 December 31, 2021
NCT03618420 Completed Phase 1/Phase 2 Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic Function October 1, 2018 August 1, 2021
NCT03632759 Completed Early Phase 1 Targeting Beta Cell Dysfunction With Liraglutide or Golimumab in Longstanding T1D August 15, 2018 November 9, 2021
NCT03635437 Completed Phase 1/Phase 2 Evaluation of Safety and Diabetes Status Upon Oral Treatment With GABA in Patients With Longstanding Type-1 Diabetes September 5, 2018 September 27, 2022
NCT03655067 Completed N/A Internet-Based Cognitive Behavioral Therapy for Depressive Symptoms in Adolescents With Type 1 Diabetes Mellitus December 15, 2020 December 1, 2021
NCT03659799 Completed Phase 4 Comparison of FiAsp and Aspart During Postprandial Exercise in Adults With Type 1 Diabetes April 12, 2019 March 30, 2023
NCT03662334 Completed Phase 4 A Study of Continuous Subcutaneous Insulin Infusion (CSII) Pump Function in Subjects With Type 1 Diabetes With Recombinant Human Hyaluronidase (rHuPH20) October 3, 2013 February 27, 2014
NCT03669770 Completed Ultrasound Classification and Grading of Lipohypertrophy and Its Impact on Glucose Variability in Type 1 Diabetes September 22, 2017 April 25, 2018
NCT03674281 Completed N/A The VRIF Trial: Hypoglycemia Reduction With Automated-Insulin Delivery System September 24, 2018 November 21, 2019
NCT00021801 Completed Phase 2 Islet Cell Transplantation Alone and CD34+ Enriched Bone Marrow Cell Infusion in Patients With Diabetes Mellitus: Steroid-Free Regimen March 2000 September 2000
NCT03680079 Completed N/A High Risk Youth With Poorly-controlled Diabetes September 1, 2018 June 30, 2019
NCT03698708 Completed N/A Cognitive Adaptations to Reduce Emotional Stress Associated With Type 1 Diabetes January 20, 2019 July 31, 2020
NCT03709108 Completed N/A Safety and Feasibility of an Insulin Sensitivity-Informed Bolus Calculator in Type 1 Diabetes November 19, 2018 March 31, 2019
NCT03738865 Completed Phase 3 G-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 Diabetes September 27, 2018 April 2, 2019
NCT03740919 Completed Phase 3 A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes April 7, 2019 July 2, 2021
NCT03743285 Completed N/A A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus (T1D) November 14, 2018 January 28, 2019
NCT03751839 Completed N/A Microarchitecture, Bone Strength and Fracture Risk in Long-term Type 1 Diabetes October 1, 2018 July 1, 2021
NCT03761615 Completed Longitudinal Observation of Insulin Requirements and Sensor Use in Pregnancy November 13, 2018 June 9, 2021
NCT03767790 Completed N/A Model Predictive Control (MPC) Artificial Pancreas vs. Sensor Augmented Pump (SAP)/Predictive Low Glucose Suspend (PLGS) With Different Food Choices in the Outpatient Setting January 3, 2019 June 27, 2019
NCT03772600 Completed N/A Comparing Continuous With Flash Glucose Monitoring in Adults With Type 1 Diabetes January 29, 2019 November 30, 2022
NCT03774186 Completed N/A Pregnancy Intervention With a Closed-Loop System (PICLS) Study March 21, 2019 March 8, 2022
NCT03784027 Completed N/A The Artificial Pancreas in Very Young Children With T1D May 1, 2019 October 3, 2022
NCT03793283 Completed Continuous Subcutaneous Insulin Infusion Versus Multiple Dose Insulin Injections in Routine Clinical Practice January 1, 2019 December 31, 2019
NCT03793673 Completed N/A CoYoT1 to California January 20, 2019 December 31, 2022
NCT03804983 Completed N/A Safety and Efficacy of Initializing the Control-IQ Artificial Pancreas System Using Total Daily Insulin January 15, 2019 February 16, 2019
NCT03818711 Completed N/A Communication and Coping for Mothers of Adolescents With Type 1 Diabetes April 1, 2019 September 2, 2023
NCT03830281 Completed Phase 3 A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump Therapy February 14, 2019 January 6, 2020
NCT03840278 Completed Phase 2/Phase 3 The Bihormonal iLet Bionic Pancreas Feasibility Study May 15, 2019 July 3, 2019
NCT03844789 Completed N/A A Study of t:Slim X2 With Control-IQ Technology June 6, 2019 March 20, 2020
NCT03845465 Completed N/A Positive Psychology Intervention to Treat Diabetes Distress in Teens With Type 1 Diabetes December 17, 2019 September 7, 2023
NCT03847194 Completed N/A PRISM for Adolescents With Type 1 Diabetes January 1, 2020 March 31, 2024
NCT03848767 Completed N/A A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus During Meal Challenges February 20, 2019 April 1, 2019
NCT03849612 Completed N/A A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus February 21, 2019 March 27, 2019
NCT03859401 Completed N/A Exercise-Induced Hypoglycemia Prevention in Adults With Type 1 Diabetes Using an Artificial Pancreas April 12, 2019 January 13, 2020
NCT03862521 Completed N/A Safety of Low and Very Low Carbohydrate Diets in Young Children With Type 1 Diabetes August 1, 2018 February 28, 2022
NCT03874715 Completed Phase 3 Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine March 11, 2019 July 8, 2020
NCT03875729 Completed Phase 3 Recent-Onset Type 1 Diabetes Trial Evaluating Efficacy and Safety of Teplizumab April 5, 2019 May 1, 2023
NCT03880760 Completed N/A The Effect of Probiotics on Type 1 Diabetes Mellitus in Children August 1, 2018 January 31, 2021
NCT03885362 Completed N/A Assessment of the Accuracy of Continuous Glucose Sensors in People With Diabetes Undergoing Haemodialysis December 11, 2019 July 1, 2022
NCT03889522 Completed The Influence of Non-Caloric Artificial Sweeteners on Youth With Type 1 Diabetes May 1, 2019 February 25, 2021
NCT03890003 Completed N/A A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes March 28, 2019 May 6, 2019
NCT03911843 Completed Phase 2/Phase 3 Omega-3 and Vitamin D Supplements in Childhood T1D January 1, 2017 December 31, 2018
NCT03916640 Completed Phase 1 A Trial to Assess a Co-formulation of an Insulin Analog and Pramlintide in Subjects With Type 1 Diabetes Mellitus January 4, 2019 March 1, 2019
NCT03919617 Completed Phase 1/Phase 2 Metabolic Pathways of GRA in Patients With Type 1 Diabetes July 1, 2019 May 31, 2022
NCT03920397 Completed N/A Mesenchymal Stem Cells in Patients With Type 1 Diabetes Mellitus March 1, 2015 May 1, 2021
NCT03941184 Completed Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity January 1, 1995 November 10, 2020
NCT03942471 Completed N/A Mindfulness for Adolescents With Type 1 Diabetes October 14, 2015 January 5, 2019
NCT03952130 Completed Phase 3 A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes May 29, 2019 January 10, 2022
NCT03959423 Completed N/A Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System July 24, 2019 October 27, 2023
NCT03966911 Completed N/A Performance Evaluation of an Advanced Algorithm With CGM in Adults, Adolescents, and Pediatrics June 14, 2019 May 13, 2020
NCT03977727 Completed Phase 3 FIasp® vs. Novolog® in Type 1 Diabetics Using 670G Medtronic Pump June 11, 2019 April 20, 2020
NCT03980353 Completed Difficulties and Obstacles to the Integration in Community of Children With Type 1 Diabetes Before Primary School. August 1, 2019 November 1, 2019
NCT03981627 Completed Phase 1/Phase 2 A Trial to Assess Safety and Efficacy of ADO09 Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus June 6, 2019 June 27, 2020
NCT03993366 Completed N/A Pramlintide and Fiasp Closed-Loop With a Simple Meal Announcement March 1, 2019 August 6, 2019
NCT04016662 Completed Phase 4 Automated Insulin Delivery in Elderly With Type 1 Diabetes (AIDE T1D) September 28, 2020 January 5, 2024
NCT04025762 Completed N/A 24/7 Closed-loop in Older Subjects With Type 1 Diabetes September 1, 2019 August 20, 2021
NCT04074668 Completed Control of Renal Oxygen Consumption, Mitochondrial Dysfunction, and Insulin Resistance January 1, 2020 November 15, 2022
NCT04075513 Completed Phase 4 Comparison of Glucose Values and Variability Between TOUJEO and TRESIBA During Continuous Glucose Monitoring in Type 1 Diabetes Patients October 9, 2019 September 16, 2021
NCT04139369 Completed Methylation of DNA in Children and Adolescents With Type 1 Diabetes Mellitus (METHYLDIAB) May 2012 August 2018
NCT04163874 Completed N/A Alleviating Carbohydrate Counting for Patients With Type 1 Diabetes Using a Novel Insulin-plus-pramlintide Artificial Pancreas February 14, 2020 January 30, 2022
NCT04176731 Completed N/A Prepivotal Omnipod Horizon™ Automated Glucose Control System December 15, 2019 January 31, 2020
NCT04190693 Completed Phase 1 IMCY-T1D-002: Long-term Follow-up Study of T1D Patients Previously Treated With IMCY-0098 or Placebo February 14, 2019 November 18, 2019
NCT04196140 Completed N/A Pivotal Omnipod Horizon™ Automated Glucose Control System December 30, 2019 April 20, 2022
NCT04213300 Completed Low Carbohydrate Diet, Glycaemic Control and Quality of Life in Australian Adults With Type 1 Diabetes January 15, 2021 November 19, 2021
NCT04378114 Completed N/A Impact of Acetaminophen on Performance of Guardian™ Sensor (3) in Adults May 18, 2020 July 17, 2020
NCT04436822 Completed N/A Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and Pediatrics July 15, 2020 April 12, 2022
NCT04450407 Completed Phase 2 A Study of LY3209590 in Participants With Type 1 Diabetes July 6, 2020 October 1, 2021
NCT04454827 Completed Fear of Hypoglycemia in Children and Adolecents With Type 1 Diabetes April 1, 2019 September 30, 2019
NCT04476472 Completed N/A Omnipod Horizon™ Automated Glucose Control System Preschool Cohort September 8, 2020 October 12, 2022
NCT04503564 Completed N/A "FEXIS": (Feasibility of an Extended Wear CSII Set in Participants With T1DM) November 13, 2019 November 11, 2020
NCT04558645 Completed Evaluation of Quality of Life in Patients With Type 1 Diabetes Mellitus During the Covid-19 Pandemic September 18, 2020 December 26, 2020
NCT04656236 Completed N/A Metabolic Effects of Exogenous 3-hydroxybutyrate in Patients With Type 1 Diabetes and Healthy Controls January 1, 2021 March 1, 2022
NCT04665999 Completed Glycemic Profiles And Insulin Delivery Across The Menstrual Cycle In Women With Type 1 Diabetes January 15, 2021 March 10, 2022
NCT04759144 Completed N/A FASter Insulin in Closed-loop Technology in Children March 12, 2021 December 1, 2022
NCT04783376 Completed Phase 4 Effect of Splitting Mealtime Insulin Doses After Mixed Meals High in Fat and Protein April 12, 2021 March 3, 2022
NCT04784637 Completed N/A Adaptive Biobehavioral Control (ABC) of Automated Insulin Delivery July 23, 2021 December 24, 2021
NCT04809285 Completed N/A Use of the Guardian™ Connect System With Smart Connected Devices April 6, 2021 September 29, 2023
NCT04816890 Completed Phase 2 A Trial to Assess the Efficacy and Safety of M1 Pram P037 Prandial Insulin in Subjects With Type 1 Diabetes (T1DM) March 23, 2021 February 24, 2022
NCT04819815 Completed Investigation of Chronotropic Index, Exercise Capacity in Type 1 Diabetes Mellitus January 20, 2020 September 30, 2021
NCT04821921 Completed The Impact of the COVID-19 Pandemic on Diabetes Management April 9, 2021 September 15, 2022
NCT04909580 Completed N/A Decision Coaching for Youth and Parents Considering Insulin Delivery Methods for Type 1 Diabetes September 5, 2013 December 5, 2015
NCT04932213 Completed Phase 3 Effect of Tropicamide 0.5% vs Tropicamide 1% on Intraocular Pressure of Diabetic Patients July 7, 2021 November 7, 2021
NCT04936633 Completed N/A Efficacy of FSGM Cloud-based Remote Intervention for Insulin-dEpendent Diabetic Patients (FRIEND) June 30, 2021 April 30, 2022
NCT05067270 Completed Phase 1 A Study of Infusion Site Pain After Infusion of Excipients in Participants With Type 1 Diabetes Mellitus October 22, 2021 December 6, 2021
NCT05141968 Completed N/A Vitamin D Supplementation and Glycemic Control Improvement Among Type 1 Diabetic Children October 1, 2017 June 16, 2021
NCT05168657 Completed N/A Feasibility of Closed-loop Automated Insulin Delivery System by Primary Care & Endocrinology, in Person & Via Telehealth March 31, 2022 May 23, 2023
NCT05179135 Completed N/A Effects of Postprandial Exercise on Glycaemia and Metabolism in People With Type 1 Diabetes January 19, 2022 November 21, 2022
NCT05211479 Completed N/A Tele Nursing Application For Type 1 Diabetes Mellitus Adolescents December 20, 2021 August 31, 2022
NCT05248841 Completed Phase 1 A Study to Demonstrate Pharmacokinetic and Pharmacodynamic Biosimilarity Between HEC-Glargine and US-Lantus® in Healthy Male Volunteers March 8, 2022 August 31, 2022
NCT05649553 Completed N/A The Effect of Diabetes Education Digital Games and Video Animation on Quality of Life September 15, 2022 September 15, 2023
NCT05857007 Completed CGM Utilization With IV Insulin EndoTool and Subcutaneous Insulin in the Neuro ICU July 19, 2023 December 31, 2023
NCT06097689 Completed N/A A Pilot Study to Assess the Feasibility of a Novel Non-invasive Technology to Measure Changing Blood Glucose Levels in Adults With Type-1 Diabetes Mellitus November 24, 2023 May 16, 2024
NCT06139913 Completed N/A Aerobic Exercise on Fitness Score and Blood Glucose Level in Adolescents Girls With Diabetes Mellitus March 15, 2023 September 17, 2023
NCT06151821 Completed N/A Examining the Influence of Guided Meditation on Diabetes-related Distress and Glycemic Control August 1, 2023 October 3, 2023
NCT00690066 Completed Phase 2 PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM) June 11, 2008 December 19, 2011
NCT00692562 Completed Phase 1/Phase 2 Simultaneous Islet-Kidney Transplantation in Patients of Type 1 Diabetes With End-stage Renal Disease June 2005 December 2007
NCT00706693 Completed N/A Skittles(TM) Effective for Treating Hypoglycemia in Children With Type 1 Diabetes August 2003 September 2006
NCT00717223 Completed A Survey To Elicit The Relationship Between Literacy And Glycemic Control In Pediatric Diabetes June 2007 July 2010
NCT00717483 Completed BMI and Its Relationship to Hypoglycemic Seizures in Children With Insulin-requiring Diabetes July 2008 May 2010
NCT00745342 Completed N/A Optimizing Adherence and Glycemia in Youth With New Insulin-dependent Diabetes Mellitus (IDDM) March 1999 October 2002
NCT00758082 Completed Phase 3 Reinforcement of the Impact of a Functional Insulin Therapy Training Course by Telemonotoring With a PDA-phone in Type 1 Diabetic Patients. The TELFIT Study Patients July 2008 March 2010
NCT00761852 Completed Phase 2/Phase 3 Signaling Mechanisms and Vascular Function in Diabetes Mellitus May 1999 October 2007
NCT00762671 Completed Phase 2/Phase 3 Signaling Mechanisms and Vascular Function in Patients With Diabetes Mellitus May 1999 October 2007
NCT00774800 Completed Phase 2 Phase II Pharmacokinetics Study of Humalog and Humulin-R With and Without rHuPH20 in Type 1 Diabetes Mellitus October 2008 March 2009
NCT00807651 Completed Phase 2 Autologous Hematopoietic Stem Cell Transplantation for Early Onset Type 1 Diabetes February 2008 December 2016
NCT00821899 Completed N/A Bone Marrow Autotransplantation in Type 1 Diabetes January 2009 May 2010
NCT00831389 Completed N/A Effect of Closed Loop Glucose Control on Exercise-Associated Hypoglycemia January 2009 November 2010
NCT00837512 Completed Phase 2/Phase 3 Insulin Delivery Using Microneedles in Type 1 Diabetes September 2008 July 2013
NCT00848822 Completed Sleep and Glucose Regulation in Youth With Type 1 Diabetes Mellitus February 2009 July 2010
NCT00873561 Completed Phase 1 A Study to Evaluate NBI-6024 in Adult and Adolescent Patients With New Onset of Type 1 Diabetes Mellitus December 2001 July 2006
NCT00879710 Completed N/A Effect of Diabetes Mellitus on Cholesterol Metabolism August 2008 July 2013
NCT00884611 Completed N/A Development of Algorithms for a Hypoglycemic Prevention Alarm: Closed Loop Study May 2007 August 2011
NCT00898534 Completed Phase 4 Effect of Immediate Hemoglobin A1c on Glycemic Control in Children With Type I Diabetes Mellitus November 2003 January 2006
NCT00905073 Completed N/A Low Dose Cyclosporin and Methotrexate Therapy in Diabetes February 1990 June 1994
NCT00913497 Completed Phase 4 The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal Children June 2009 January 2012
NCT00918801 Completed Pilot Study of Hippocampal Function in Type 1 Diabetes Mellitus (T1DM) April 2007 October 2016
NCT00933101 Completed Vascular Inflammation in Adolescents With Type 1 Diabetes January 2010 June 2011
NCT00939289 Completed Concurrent Use of Two Continuous Glucose Monitoring Systems in Adults With Type 1 Diabetes Mellitus (T1DM) July 2008 February 2009
NCT00945659 Completed N/A Use of Continuous Glucose Sensors by Adolescents With Inadequate Diabetic Control August 2009 June 30, 2017
NCT00962026 Completed Phase 1 Rilonacept in Diabetes Mellitus Type 1: Safety Study February 2011 June 2013
NCT00993473 Completed Phase 3 6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 Diabetes October 2009 March 2011
NCT01017718 Completed Nerve Conduction Velocity in Diabetic Children May 2009 July 2011
NCT01019486 Completed Phase 4 Regadenoson Blood Flow in Type 1 Diabetes (RABIT1D) November 2009 December 2011
NCT01029392 Completed Phase 3 Prevalence of Vitamin D Deficiency in Type 1 Diabetes Mellitus and Effect of Supplementation on Insulin Requirements November 2009 June 2012
NCT01050166 Completed MRI Imaging of Labeled Human Islets Transplanted Into the Liver August 15, 2008 December 31, 2012
NCT01053728 Completed Phase 1/Phase 2 Study of How Single Rising Doses of SAR161271 Are Absorbed and Act in Patients With Type 1 Diabetes Mellitus (T1DM) February 2010 November 2010
NCT01069393 Completed N/A Alternative Delivery of Dose Adjustment For Normal Eating (DAFNE) Trial in Patients With Type 1 Diabetes June 2010 June 2012
NCT01083433 Completed N/A Study to Find Out if Intensive Diabetes Clinic and Continuous Glucose Monitors Help Teenagers With Diabetes May 2010 October 2011
NCT01097551 Completed Endothelial Dysfunction and Diabetes January 2011 July 2011
NCT01103284 Completed Phase 3 Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults April 2010 October 2014
NCT01104142 Completed Efficacy of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes Mellitus on Multiple Daily Injections (MDI) or Continuous Subcutaneous Insulin Infusion (CSII) Therapy April 2009
NCT01110746 Completed Phase 3 To Evaluate the Effect on Post-prandial Glycemia Safety, and Tolerability of Viaject 7 vs. Lispro Insulin During Subcutaneous Insulin Pump Therapy February 2010 June 2010
NCT01112696 Completed N/A An Inpatient Performance Evaluation of a New Subcutaneous Glucose Sensor April 2010 November 2010
NCT01121029 Completed Phase 1/Phase 2 Hematopoietic Stem Cell Transplantation in Type 1 Diabetes Mellitus May 2010 December 2012
NCT01145547 Completed N/A Continuous Glucose Monitoring to Measure Effect of Glycemic Index April 2009 October 2009
NCT01146678 Completed Phase 1 Relative Bioavailability and Activity of Different Formulations of Insulin Glargine and Lixisenatide in Patients With Diabetes Mellitus Type 1 June 2010 January 2011
NCT01148862 Completed N/A Assess the Efficacy of the Low Glucose Suspend (LGS) Feature in the MiniMed Paradigm® X54 System June 2010 November 2011
NCT01161043 Completed N/A New Glucose Sensor Pediatric July 2010 November 2010
NCT01170832 Completed To Evaluate if Wide Blood Sugar Fluctuations Lead to Injury of Heart Function and Heart Nerves May 2010 August 2016
NCT01176253 Completed Detection of Human Beta Cell Death in Type 1 Diabetes Mellitus (T1DM) by Methylation Specific Polymerase Chain Reaction (PCR) July 2009 April 2015
NCT01195454 Completed Phase 1 Euglycemic Clamp Dose-response Study Comparing a New Insulin Glargine Formulation With Lantus® August 2010 December 2010
NCT01210664 Completed Phase 1 T1DM Immunotherapy Using CD4+CD127lo/-CD25+ Polyclonal Tregs November 2010 January 2017
NCT01220479 Completed N/A Exercise Training Intervention in Children With Type 1 Diabetes September 2001 June 2009
NCT01223131 Completed Phase 3 Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old. February 2011 March 2014
NCT01261052 Completed Phase 2 Real-time Adaptation to Changes in Insulin Sensitivity November 2010 April 2011
NCT01275131 Completed Phase 1 Randomized, Double-blind, Crossover, Pharmacokinetic (PK) and Glucodynamic (GD) Study of Continuous Subcutaneous Insulin Infusion (CSII) in Participants With Type 1 Diabetes Mellitus (T1DM) January 2011 December 2011
NCT01276743 Completed Study of PTPN22 C1858T Polymorphism in Children and Adolescents of Greek Origin With T1DM February 2010 February 2013
NCT01279161 Completed The Role of FTO Gene Polymorphism and Insulin Preparation in Obesity in Children With Type 1 Diabetes Mellitus December 2010 December 2014
NCT01279928 Completed Detection of Vascular Injury in Diabetes Through Eye and Nailfold Data (DIVIDEND) - A Pilot Study March 2010 October 2010
NCT01299012 Completed Liraglutide as Additional Treatment in Patients With Type 1 Diabetes Mellitus October 2010 June 2013
NCT01304537 Completed Phase 1/Phase 2 Study of the Safety and Efficacy of Intravenous Alpha-1 Antitrypsin in Type 1 Diabetes Mellitus June 2011 November 2012
NCT01311076 Completed Phase 1 TAK-329 Glucose Clamp Study March 2011 January 2012
NCT01315171 Completed N/A Effect of a Medium Chain Triglyceride Supplemented Diet on Cognitive Function and Brain Activation in Type 1 Diabetes. January 2012 October 2016
NCT01331343 Completed Phase 4 Effectiveness Study of the Guardian RT in Type 1 Diabetics June 2004 June 2005
NCT01349855 Completed Phase 1 Repeated Dosing Study With a New Insulin Glargine Formulation and Lantus® in Patients With Type 1 Diabetes Mellitus March 2011 May 2011
NCT01368978 Completed Phase 3 Pediatric Diabetics Type 1 Using InsuPatch December 2009 May 2012
NCT01371955 Completed Impact of c242T Polymorphism of p22phox in Diabetic type1 Nephropathy January 2011 March 2013
NCT01390259 Completed N/A Hypoglycemia Prevention After Exercise in Adolescent T1DM Patients Using a Control to Range System January 2010 February 2011
NCT01400659 Completed Phase 4 Pizza-Salami Study in Children and Adolescents With Type 1 Diabetes March 2009 November 2009
NCT01401127 Completed Managing Insulin Pumps for Exercise - Study 1 January 2011 August 2011
NCT01401751 Completed N/A Feasibility Study Assessing The Ability Of An Insulin Pump-Controlling Algorithm To Minimize Hypoglycemia And Hyperglycemia In Patients With Type 1 Diabetes In A Clinical Research Setting July 1, 2011 December 1, 2011
NCT01418703 Completed N/A Feasibility Study of a Modular Control to Range System in Type 1 Diabetes Mellitus October 2009 December 2010
NCT01421225 Completed N/A Closed-Loop Insulin Delivery in Children Less Than 7 Years of Age August 2011 August 15, 2013
NCT01421355 Completed Phase 1 A Pilot Study of Moderate Hyperbilirubinemia in Type 1 Diabetes Mellitus May 2012 February 2014
NCT01439672 Completed N/A Insulin Sensitivity, Impaired Counterregulation, and Glucose Variability August 2010 March 2012
NCT01440140 Completed Phase 2 Closing the Loop in Adults With Type 1 Diabetes in the Home Setting December 2012 January 2014
NCT01445951 Completed Phase 3 Clinical Trial Evaluating Technosphere® Insulin Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Over a 24-week Treatment Period September 2011 June 2013
NCT01447979 Completed Early Phase 1 Feasibility Study of a Portable Artificial Pancreas System in Type 1 Diabetes Mellitus (T1DM) - Montpellier March 2012 April 2012
NCT01447992 Completed Early Phase 1 Feasibility Study of a Portable Artificial Pancreas System in Type 1 Diabetes Mellitus (T1DM) - Padova September 2011 April 2012
NCT01454700 Completed Phase 4 Effect of CSII and CGM on Progression of Late Diabetic Complications December 2011 December 2014
NCT01464346 Completed N/A A Performance Evaluation of the Enlite Glucose Sensor to Support a Full 144 Hours(6Days) of Use November 2011 March 2012
NCT01469715 Completed Phase 2 A Clinical Study of the Performance of a Glucose Blinding Protein-Based Continuous Glucose Monitor (GBP CGM) November 2011 July 2012
NCT01470807 Completed N/A Pilot Study 1 of Outpatient Control-to-Range - System and Monitoring Testing October 2011 December 2011
NCT01472406 Completed Early Phase 1 Feasibility Study Using Zone-MPC Controller (Zone-Model Predictive Control) and Health Monitoring System (HMS) November 2011 March 2014
NCT01483651 Completed N/A Physiologic Response to Glucagon at Varying Insulin Levels November 2011 March 2013
NCT01493115 Completed Phase 1 Single Dose Study With a New Insulin Glargine Formulation and Lantus® in Japanese Patients With Type 1 Diabetes Mellitus November 2011 April 2012
NCT01497912 Completed Phase 4 Treatment Effects of Atorvastatin on Hemostasis and Skin Microcirculation in Patients With Type 1 Diabetes January 2005 January 2010
NCT01498185 Completed Phase 2 BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes February 2012 October 2012
NCT01526733 Completed Phase 4 Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human Hyaluronidase December 2011 September 2013
NCT01534013 Completed N/A Clinical Assessment of a Closed-loop Insulin Delivery System August 2011 August 2018
NCT01544881 Completed Phase 1 Comparison of Technosphere Insulin Inhalation Powder & Subcutaneous Rapid-Acting Analog in Subjects With Type 1 Diabetes March 2012 January 2013
NCT01554566 Completed Phase 2 Metabolic Effects of Honey in Type 1 Diabetes Mellitus January 2010 October 2011
NCT01555788 Completed N/A DiaPort Closed-Loop Artificial Pancreas February 2012 March 2013
NCT01578980 Completed N/A Outpatient Control-to-Range: System and Monitoring Testing April 2012 June 2012
NCT01582139 Completed N/A Feasibility Study of Closed Loop Control in Type 1 Diabetes Using Heart Rate Monitoring as an Exercise Marker May 2012 August 2012
NCT01588093 Completed N/A IGF-I Induced Muscle Glucose Uptake and Interstitial IGF-I Concentrations April 2011 September 2011
NCT01605149 Completed Type 1 Diabetes Mellitus Bone Mineral Density in Childhood and Adolescence July 2012 May 2013
NCT01621308 Completed Intraperitoneal vs Subcutaneous Insulin Administration in Type 1 Diabetes Mellitus December 2012 March 2014
NCT01626586 Completed N/A Diabetes Adolescent and Family Group Therapy May 2012 February 24, 2020
NCT01638299 Completed Phase 1 Study Assessing an Insulin Pump-controlling Algorithm to Minimize Hypo and Hyper in Type 1 During CRC Setting July 2012 September 2012
NCT01653210 Completed Development of an Advisory System for Glycemic Control During the Menstrual Cycle in Patient With Type 1 Diabetes August 2012 September 2013
NCT01658579 Completed Phase 2 Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus on Basal Plus Mealtime Insulin August 2012 May 2013
NCT01665716 Completed Ovarian Ageing in Type 1 Diabetes Mellitus July 2011 March 2014
NCT01668485 Completed Phase 4 Mechanisms of Glucose Counterregulation in Pancreatic Islet Transplantation November 2001 November 2011
NCT01676233 Completed Phase 1 Repeated Dose Study With a New Insulin Glargine Formulation and Lantus® on 24-hour Glucose Profile in Japanese Patients With Type 1 Diabetes Mellitus September 2012 August 2013
NCT01677546 Completed N/A Bolus Calculator and Wireless Communication With Blood Glucose Meter in Management of Type 1 Diabetes Mellitus (T1DM). January 2011 July 2012
NCT01678235 Completed Phase 4 Insulin Glulisine and Aspart in Postprandial Glycemic Control After High-GI Meal in Children With Type 1 Diabetes Mellitus September 2011 September 2012
NCT01683266 Completed Phase 3 Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus September 2012 March 2014
NCT01686620 Completed Phase 2 A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®) August 2012 June 2013
NCT01689129 Completed Phase 3 Comparison of a New Formulation of Insulin Glargine With Lantus® in Japanese Patients With Type 1 Diabetes Mellitus September 2012 April 2014
NCT01697150 Completed N/A Outpatient Control-to-Range: System and Monitoring Testing April 2012 December 2015
NCT01724814 Completed Phase 1 A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A December 20, 2012 July 1, 2014
NCT01727661 Completed Cardiopulmonary Fitness, Lung Function, Muscular Oxygen Saturation, and Quality of Life in T1DM February 2012 January 2013
NCT01733524 Completed N/A Pet Ownership and Glucose Control in Type 1 Diabetes October 2012 December 2015
NCT01742208 Completed Phase 2 Safety and Efficacy of Sotagliflozin (LX4211) in Patients With Inadequately Controlled Type 1 Diabetes Mellitus February 2013 January 2014
NCT01779141 Completed Orchestra Pregnancy Observational Study in Poland May 2013 August 2017
NCT01781975 Completed Phase 2 Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus January 2014 May 2018
NCT01782547 Completed N/A Telehealth Intervention for Youth With T1DM June 2013 May 2014
NCT01787903 Completed N/A The Effects of RT-CGM on Glycemia and QoL in Patients With T1DM and IHA February 2013 April 2016
NCT01792284 Completed Phase 3 A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus February 2013 April 2014
NCT01794650 Completed N/A Guidelines for Post-exercise Dietary Intake in T1DM March 2013 November 2013
NCT01823406 Completed N/A Tissue-Specific Metabolic Reprogramming in Diabetic Complications May 2012 August 2017
NCT01848990 Completed Phase 4 CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM) March 2013 September 2014
NCT01871870 Completed Phase 2 Artificial Pancreas Control System in an Outpatient Setting May 2013 October 2013
NCT01874392 Completed N/A Feasibility Study Using Zone-MPC Controller, HMS and Technosphere® Insulin Inhalation System From MannnKind Corp October 2012 June 2013
NCT01881009 Completed N/A Medtronic Minimed Overnight Closed-Loop System June 2013 August 3, 2013
NCT01887431 Completed N/A Telecare in Type 1 Diabetes (T1D) Patients Treated by Insulin Pump October 2013 November 2016
NCT01925989 Completed Phase 1 A Study of How Insulin Peglispro (LY2605541) and Insulin Glargine Affect the Breakdown of Fat and Sugar in Type 1 Diabetics November 2013 October 2015
NCT01929798 Completed Early Phase 1 Crossover Feasibility Study of Portable AP Device With Zone-MPC and HMS and Adapted I:C and Basal Insulin November 2013 November 2014
NCT01939522 Completed Phase 4 Protection Against Pneumococcal Infection in Children With T1DM August 2013 January 2017
NCT01945060 Completed N/A Closed Loop Control in Adolescents Using Heart Rate as Exercise Indicator September 2013 April 2015
NCT01986231 Completed N/A Safety Study of Repeated Doses of Glucagon on Animal Starch in the Liver January 2011 December 2012
NCT01987206 Completed Early Phase 1 Feasibility Study of PID Versus MPC and HMS July 2014 August 2015
NCT02004964 Completed Screening of Subjects With Type I Diabetes to Determine Eligibility for Islet Transplantation April 2009 November 6, 2018
NCT02019186 Completed Phase 4 Effects of Vitamin C and E on Endothelial Function in Adolescent Diabetes December 2013 January 2015
NCT02028078 Completed Phase 2 Pilot Study Investigating the Feasibility of Determining the Endogenous Glucose Production During a Hypoglycaemia January 2014 March 2016
NCT02059161 Completed Phase 3 A Study of the Safety and Efficacy of MK-1293 Compared to Lantus™ in Participants With Type 1 Diabetes Mellitus (T1DM) (MK-1293-003) October 17, 2013 November 12, 2015
NCT02059174 Completed Phase 1 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-1293 Compared With a Basal Insulin in Participants With Type 1 Diabetes (MK-1293-005) February 10, 2014 April 27, 2015
NCT02068638 Completed N/A Impact of Physical Activity on Blood Glucose Stability and Energy Stores in Individuals With Type 1 Diabetes February 2014 July 2016
NCT02099409 Completed N/A Safety and Efficacy of Overnight Closed Loop in Children With Type 1Diabetes Mellitus in Luxembourg January 2014 August 2014
NCT02131675 Completed Detection of C-peptide in Youth With Longstanding Type 1 Diabetes Mellitus October 2012 December 2013
NCT02137031 Completed N/A Continuous Glucose Monitoring and Metabolic Control in Children With Type 1 Diabetes September 2012 April 2014
NCT02138045 Completed N/A Treatment of Diabetic Neuropathy With Liraglutide May 2014 February 2017
NCT02144337 Completed N/A Physical Activity in Children With Type 1 Diabetes Study May 2014 May 2015
NCT02146404 Completed N/A The Effect of Hypoglycaemia on Brain Lactate Accumulation and Cerebral Blood Flow August 2014 October 2015
NCT02153190 Completed Phase 2 Hybrid Artificial Pancreas in Home Setting May 2014 June 2015
NCT02175732 Completed N/A Reducing Distress And Improving Glycemic Control In Adults With Type 1 Diabetes September 2014 December 2018
NCT02179281 Completed N/A Prevention of Hypoglycaemia With Predictive Insulin Suspend Using Sensor Augmented Insulin Pump in Children October 2014 February 2015
NCT02192450 Completed Phase 4 Insulin Degludec and Symptomatic Nocturnal Hypoglycaemia January 2015 February 28, 2019
NCT02194517 Completed N/A Impact of ELKa, the Toolset for Food Exchanges Calculation on Metabolic Control in Pediatric Diabetic Patients. April 2013 November 2014
NCT02199028 Completed Phase 1 Hyaluronidase Effect on Infusion Set Life July 2014 March 2015
NCT02201199 Completed Phase 1 Single Dose Clamp Study To Compare Concentration/Time Profile And Metabolic Activity Profile Of 2 New Formulations Of Insulin Glargine With Lantus August 2014 November 2014
NCT02204397 Completed Phase 2 Study of Tolerability and Safety of Adding Ustekinumab to INGAP Peptide for 12 Weeks in Adult Patients With TD1 Melitis November 2015 March 8, 2017
NCT02204839 Completed N/A Combined Basal-bolus Insulin and Post-exercise Carbohydrate Feeding Strategy in T1DM January 2014 January 2015
NCT02208115 Completed N/A Post-exercise Appetite Responses in Type 1 Diabetes November 2013 November 2013
NCT02232698 Completed N/A An Evaluation of Novel Glucose Sensing Technology on Hypoglycaemia in Type 1 Diabetes (IMPACT) September 2014 October 2015
NCT02241993 Completed The Multi-Sensor Distance Accuracy Study July 2010 January 2011
NCT02246712 Completed Phase 4 Influence of Diabetes on Tramadol Pharmacokinetics June 2008 December 2011
NCT02268214 Completed Phase 3 Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes November 11, 2014 August 25, 2017
NCT02269735 Completed Phase 1 A Three-part Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-2640 in Healthy Participants (Part I) and Participants With Type 1 Diabetes Mellitus (Parts II and III) (MK-2640-001) November 26, 2014 July 29, 2016
NCT02273180 Completed Phase 3 Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine October 2014 July 2016
NCT02278926 Completed Lypo-hypertrofia Characterization in Diabetes January 2012 October 2014
NCT02293837 Completed Phase 2 Tocilizumab (TCZ) in New-onset Type 1 Diabetes March 12, 2015 August 31, 2020
NCT02302963 Completed N/A USS Virginia Closed-Loop Versus SAP Therapy for Hypoglycemia Reduction in T1D June 2015 January 2017
NCT02308293 Completed N/A The Role of Endogenous Lactate in Brain Preservation and Counterregulatory Defenses Against Hypoglycemia January 2015 July 2016
NCT02344602 Completed Phase 4 The Effect of Uric Acid Lowering in Type 1 Diabetes December 18, 2012 September 22, 2015
NCT02360254 Completed Effects of Shifting From Twice Daily Insulin Glargine or Detemir to Once Daily Insulin Degludec in Type 1 Diabetes January 2015 February 2016
NCT02367534 Completed Phase 1/Phase 2 Islet Transplantation Through an Indwelling Catheter in the Umbilical Vein June 2008 December 2013
NCT02372253 Completed Phase 2 Verapamil for Beta Cell Survival Therapy in Type 1 Diabetes February 2015 December 2019
NCT02374879 Completed N/A User Performance and System Accuracy Evaluations Using Glucose Adjustment February 1, 2015 February 1, 2015
NCT02383940 Completed Phase 2 Efficacy and Safety of Sotagliflozin in Young Adult Patients With Type 1 Diabetes Mellitus and Elevated Hemoglobin A1C April 2015 September 2016
NCT02384941 Completed Phase 3 Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy March 2015 February 2017
NCT02408705 Completed Phase 2 Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes Subjects January 2015 May 2016
NCT02421510 Completed Phase 3 Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy May 2015 June 23, 2017
NCT02432586 Completed N/A Pilot Study: Intensive Education in a Residential Camp Setting for Families of Young Children With Type 1 Diabetes July 2014 January 2017
NCT02438670 Completed N/A MPC Versus PID for Closed Loop Insulin Delivery May 2015 September 2015
NCT02459899 Completed Phase 2 Dose-ranging Study in Patients With Type 1 Diabetes Mellitus July 2015 August 2016
NCT02460978 Completed Phase 3 Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes July 8, 2015 April 18, 2018
NCT02462785 Completed N/A An Evaluation of Internet-based Carbohydrate Counting Education for Adolescents With Type 1 Diabetes July 2014 September 2016
NCT02470637 Completed Phase 1 Single Dose Clamp Study to Evaluate Concentration-time Profile and Metabolic Activity of 3 Dose Levels of Afrezza and 3 Dose Levels of Insulin Lispro in Patients With Type 1 Diabetes Mellitus June 2015 September 2015
NCT02485327 Completed Phase 1 PK and PD Within-Subject Variability of a Single Dose of Afrezza Inhaled Technosphere Insulin in Patients With Diabetes Mellitus Type 1 (T1DM) July 2015 November 2015
NCT02496156 Completed N/A Shared Medical Decision Making in Pediatric Diabetes February 2015 February 7, 2017
NCT02500979 Completed Phase 1 Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus August 17, 2015 August 5, 2016
NCT02514954 Completed Phase 1 Postprandial Blood Glucose Control With BioChaperone® Combo and Insulin Lispro (Humalog®) Mix 25 in People With Type 1 Diabetes Mellitus July 2015 November 2015
NCT02516150 Completed Phase 4 Effect of Ethanol Intoxication on the Anti-Hypoglycemic Action of Glucagon March 2016 June 2017
NCT02518945 Completed Phase 3 Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes August 2015 April 2016
NCT02520076 Completed Phase 1/Phase 2 Aralast NP in Islet Transplant August 2015 September 30, 2019
NCT02527265 Completed Phase 2 Afrezza Safety and Pharmacokinetics Study in Pediatric Patients September 28, 2017 June 25, 2020
NCT02528396 Completed Phase 1 To Investigate the Efficacy and Safety of Individualized Doses of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 1 Diabetes Mellitus August 2015 December 2015
NCT02529449 Completed Phase 2 Pharmacodynamics, Pharmacokinetics, and Safety of ASP1941 in Patients With Type 1 Diabetes Mellitus September 1, 2015 March 19, 2016
NCT02530450 Completed Continuous Glucose Monitor in Children With Poorly Controlled Diabetes May 2011 March 2013
NCT02558491 Completed N/A Feasibility of a Decision Support System to Reduce Glucose Variability in Subject With T1DM September 2015 February 2017
NCT02562313 Completed Phase 1 A Trial Investigating the Continuous Subcutaneous Insulin Infusion of a Liquid Formulation of BioChaperone Insulin Lispro in Comparison to Humalog® September 2015 November 2016
NCT02582814 Completed Phase 3 The Safety and Efficacy of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM October 26, 2015 June 15, 2017
NCT02582840 Completed Phase 1 The PK and PD of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM October 2015 June 2016
NCT02596204 Completed N/A Diabetes Care Transformation: Diabetes Data Registry and Intensive Remote Monitoring September 2015 December 2016
NCT02603510 Completed Phase 1 Assessment of the Safety of SAR342434 and Humalog® When Administered as Continuous Subcutaneous Insulin Infusion November 2015 April 2016
NCT02604524 Completed N/A Reducing Risks and Improving Glucose Control During Extended Exercise in Youth With T1DM: The AP Ski Camp January 2016 April 2016
NCT02625636 Completed Phase 1 A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Doses of SAR438544 in Comparison to Placebo and Glucagon in Healthy Subjects and Type 1 Diabetes Mellitus Patients December 2015 February 2016
NCT02657083 Completed N/A Prevention of Hypoglycemia After Exercise Using Closed Loop System in Children and Adolescents With Type 1 Diabetes January 2016 June 2016
NCT02662842 Completed BD FlowSmart™ Subcutaneous Insulin Infusion Set User Preference and Claims Study January 2016 February 2016
NCT02666430 Completed Phase 3 Extension Study to Assess Safety and Efficacy of Mylan's Insulin Glargine and Lantus® in Type 1 Diabetes Mellitus (T1DM) Patients December 2015 July 2017
NCT02688933 Completed Phase 4 A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes Mellitus May 5, 2016 June 19, 2017
NCT02705053 Completed Phase 3 At Home Study of a Zone-Model Predictive Control (MPC) Controller and a Health Monitoring System (HMS) With the Diabetes Assistant (DiAs) System and Run-to-Run Adaptation February 2016 August 2016
NCT02713841 Completed Phase 1/Phase 2 Pharmacologic Response and Safety of Inhaled Insulin in Type 1 Diabetes May 2013 July 2013
NCT02715193 Completed Phase 1 Single-dose Study to Evaluate Safety, Tolerability, and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus March 2016 January 2017
NCT02734667 Completed N/A Initiation of Continuous Glucose Monitoring at Diagnosis of Type 1 Diabetes February 2016 February 2020
NCT02735044 Completed Phase 3 Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes Mellitus April 14, 2016 December 20, 2018
NCT02739906 Completed Phase 1/Phase 2 A Trial to Investigate Post Prandial Blood Glucose Control With Fast-acting Human Insulin HinsBet® Compared to Insulin Lispro (Humalog®) and Regular Human Insulin (Huminsulin® Normal) After Ingestion of a Standardized Meal in Subjects With T1DM April 2016 August 2016
NCT02746627 Completed N/A Check It! Positive Psychology Intervention to Improve Adherence in Adolescents With T1D January 2014 February 2016
NCT02758483 Completed N/A Glucose Variability in Patients With Type 1 Diabetes With a Sucrose-added Diet March 23, 2017 January 1, 2018
NCT02772679 Completed Phase 1 T1DM Immunotherapy Using Polyclonal Tregs + IL-2 August 2016 August 27, 2021
NCT02794155 Completed Phase 2 Study of HDV Insulin Versus Insulin in Type 1 Diabetes Subjects (ISLE-1) June 2016 June 15, 2018
NCT02807155 Completed N/A Let's Empower and Prepare Young Adults With Type 1 Diabetes October 2009 July 2020
NCT02812498 Completed N/A Teleconsultation in Type 1 Diabetes Mellitus January 2015 September 2018
NCT02813421 Completed N/A Continue Glucose Monitoring Before Insulin Pump March 2016 May 1, 2017
NCT02848261 Completed N/A Remote Monitoring of Diabetes in Young Children With Type 1 Diabetes August 15, 2016 April 2019
NCT02849288 Completed Phase 1 Bigfoot Biomedical Clinical Research Center (CRC) Trial July 2016 December 2016
NCT02874612 Completed Psychosocial Functioning in Young Adults With Type 1 Diabetes August 2015 December 2018
NCT02882737 Completed N/A The Impact of Subcutaneous Glucagon Before, During and After Exercise a Study in Patients With Type 1 Diabetes Mellitus September 2016 July 11, 2017
NCT02897219 Completed Phase 3 A Study of ASP1941 in Combination With Insulin in Patients With Type 1 Diabetes Mellitus August 29, 2016 March 15, 2018
NCT02910271 Completed Clinical Features and Prevalence of Asymptomatic Peripheral Artery Disease in Patients With Type 1 Diabetes Mellitus May 2016 March 2018
NCT02912728 Completed N/A Strategies to Enhance New CGM Use in Early Childhood (SENCE) January 30, 2017 June 30, 2019
NCT02929953 Completed Prematurity Prevalence Among T1D Patients and Its Characteristics Compared With Premature-born Non-diabetic Patients January 2014 April 2019
NCT02938806 Completed The Effects of Type 1 Diabetes Mellitus and Increased Weight on Gut Microbiome and Urine Metabolome Profiles in Children June 2016 December 2021
NCT02939118 Completed One-Year Follow-up Safety Study in Subjects Previously Implanted With VC-01™ November 7, 2016 February 8, 2024
NCT02940873 Completed N/A Hypoglycaemia Awareness Restoration Programme March 9, 2017 April 27, 2021
NCT02971202 Completed Phase 1 Contribution of Hyperinsulinemia vs. Hyperglycemia to Insulin Resistance in Type 1 Diabetes and Maturity Onset Diabetes of the Young, Type 2 (MODY2) December 2016 February 2019
NCT02980627 Completed N/A iOmit: Reducing Intentional Insulin Misuse in Type 1 Diabetes March 2016 May 2, 2019
NCT03040414 Completed N/A Fuzzy Logic Automated Insulin Regulation June 3, 2019 April 20, 2020
NCT03064906 Completed N/A Insulet Artificial Pancreas Evaluating Meal Performance and Moderate Exercise (IDE2) March 18, 2017 April 7, 2017
NCT03078491 Completed N/A Technological Advances in Glucose Management in Older Adults March 30, 2017 October 1, 2022
NCT03090451 Completed N/A Exercise Physiology Study May 1, 2017 June 18, 2019
NCT06113588 Enrolling by invitation Transition of Care in Type 1 Diabetes Mellitus June 9, 2023 June 9, 2028
NCT03205865 Enrolling by invitation Diabetes Autoimmunity Study in the Young December 6, 1993 April 30, 2025
NCT00948493 No longer available Treatment Use of Generex Oral-lyn™ in Patients With Diabetes
NCT01049633 No longer available B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure
NCT06369649 Not yet recruiting N/A Coolsense and Buzzy Use on Pain Score and Anxiety Level During Insulin Injection Application June 1, 2024 December 31, 2025
NCT06180616 Not yet recruiting Phase 2 Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or Obesity June 2024 April 2026
NCT06411548 Not yet recruiting N/A Insulearn Feasibility With MDI June 1, 2024 December 31, 2024
NCT04698330 Not yet recruiting Phase 4 Effects Of Berberine Plus Inulin On Diabetes Care in Patients With LADA May 2022 December 2026
NCT05566977 Not yet recruiting Phase 1 Autologous Adoptive T Regulatory Cell Transfer in Autoimmune Diseases. December 2022 August 2024
NCT06361680 Not yet recruiting Early Phase 1 Effect of Coenzyme Q10 on Diabetic Children October 30, 2024 November 30, 2025
NCT06062069 Recruiting Phase 2 A Study of CT-868 in Type 1 Diabetes Mellitus October 19, 2023 October 31, 2024
NCT05764850 Recruiting Mechanisms of Type 1 Diabetes Endophenotypes February 1, 2023 February 1, 2026
NCT06081231 Recruiting Android Artificial Pancreas System Use Among Patients With Type 1 Diabetes Mellitus in China June 1, 2021 August 1, 2024
NCT04335656 Recruiting Phase 2 Reducing Innate Inflammation in New Onset Type 1 Diabetes April 1, 2021 December 31, 2026
NCT06382350 Recruiting Glycemic Excursions in Patients With Type 1 Diabetes Mellitus Using Closed-loop Systems May 29, 2024 May 2026
NCT03845114 Recruiting N/A Insulin-based Strategies to Prevent Hypoglycemia During Two Types of Exercise June 30, 2019 February 15, 2024
NCT06272695 Recruiting Phase 1 Glucagon Rescue of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes Treated With Volagidemab February 15, 2024 June 15, 2025
NCT06280703 Recruiting Phase 1 A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM) May 15, 2024 February 2025
NCT02734277 Recruiting Type 1 Diabetes Extension Study August 18, 2016 March 2025
NCT03860558 Recruiting N/A Impact of Metabolic Health on Sperm Epigenetic Marks in Humans May 1, 2018 July 1, 2024
NCT03899402 Recruiting Phase 2/Phase 3 Triple Therapy in T1DM May 1, 2019 March 1, 2025
NCT04590872 Recruiting Phase 1 An Immunotherapy Vaccine (PIpepTolDC) for the Treatment of Patients With Type 1 Diabetes June 16, 2022 December 10, 2024
NCT03878459 Recruiting Phase 4 Dapagliflozin Plus Pioglitazone in T1DM August 8, 2019 January 2025
NCT03463564 Recruiting Phase 4 Insulin Pump vs Multiple Daily Injections of Insulin and Glyco-metabolic Control in Type 1 Diabetic Patients January 2016 December 2026
NCT03073577 Recruiting Phase 1 Islet Transplantation Using PKX-001 February 17, 2017 September 2024
NCT06390371 Recruiting N/A Implementing the Spotlight AQ Platform in Adolescent/ Young Adult (16-25 Years Old) Type 1 Diabetics (T1D) May 27, 2024 December 2024
NCT04902378 Recruiting N/A Closed-loop Insulin Delivery In Type 1 Diabetes Pregnancies (CIRCUIT) June 15, 2021 January 2026
NCT06111586 Recruiting Phase 2 FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS) December 11, 2023 October 27, 2028
NCT04039945 Recruiting Fr1da-/Fr1da-Plus-Study in Bavaria: Early Detection for Early Care of Type 1 Diabetes February 2015 December 2028
NCT03624062 Recruiting Phase 1 MER3101: MAS-1 Adjuvanted Antigen-specific Immunotherapeutic for Prevention and Treatment of Type 1 Diabetes August 31, 2020 December 10, 2025
NCT03720197 Recruiting Registry of Patients Living With Type 1 Diabetes February 20, 2019 March 31, 2026
NCT04096794 Recruiting Chinese Alliance for Type 1 Diabetes Multi-center Collaborative Research September 2016 September 2027
NCT05901831 Recruiting Phase 3 A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes February 26, 2024 October 2, 2025
NCT02916680 Recruiting N/A Pancreatic Islet Transplantation in the Anterior Chamber of the Human Eye - a Pilot Study March 2016 April 2025
NCT03941132 Recruiting Phase 2/Phase 3 Clinical Phase II/III Trial of Ustekinumab to Treat Type 1 Diabetes (UST1D2) January 4, 2021 November 2026
NCT01999361 Recruiting N/A Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss January 2009 December 2026
NCT01999374 Recruiting Long Term Follow up of Recipients of Functional Islet Allografts March 2013 December 2027
NCT05018585 Recruiting Phase 3 A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes May 19, 2022 December 31, 2025
NCT03513939 Recruiting Phase 1/Phase 2 A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch™ for Clinical Islet Transplantation February 7, 2019 September 2025
NCT03228732 Recruiting Early Phase 1 The Effects of Fluoxetine and/or DHEA December 19, 2017 December 15, 2026
NCT02000687 Recruiting Long Term Surveillance of Islet Transplant Recipients Following Complete Graft Loss December 2008 July 2027
NCT05754281 Recruiting The PRECISION II Study: Evaluating the Accuracy of the LabPatch Glucose Sensing System February 3, 2023 December 31, 2025
NCT01320345 Recruiting Phase 3 The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye. November 3, 2016 December 2025
NCT03269084 Recruiting Type 1 Diabetes Prediction and Prevention (DIPP) Study November 7, 1994 December 31, 2024
NCT05059860 Recruiting Dexcom Hybrid Closed Loop Insulin Pump Study in Type 1 Diabetes June 9, 2023 November 2025
NCT03929601 Recruiting Phase 2 Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes October 30, 2023 October 2029
NCT06464640 Recruiting N/A Development and Evaluation of Online Interactive Podcast Program "Living With Type 1 Diabetes to Grown-Up" June 14, 2024 December 31, 2027
NCT06152042 Suspended Phase 2 Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus December 28, 2023 August 31, 2025
NCT03534193 Suspended N/A Effectiveness of Using Educational Modules Via Bedside Tablet in Newly Diagnosed Type 1 Diabetes April 17, 2017 March 30, 2025
NCT01434862 Terminated N/A Pramlintide Combined With Model Predictive Control Algorithm February 2011 February 2012
NCT03161964 Terminated Phase 2 Propranolol in Treating Hypoglycemia Unawareness October 19, 2017 December 19, 2019
NCT00439985 Terminated N/A Improving Metabolic Control in Diabetic Young Children September 2006 July 2009
NCT03262116 Terminated Phase 2/Phase 3 Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas March 19, 2019 July 23, 2019
NCT00642616 Terminated Phase 3 Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease March 2009 November 2014
NCT00468442 Terminated Phase 2 B-Lymphocyte Immunotherapy in Islet Transplantation November 2006 September 2011
NCT03785236 Terminated Visualizing Beta Cells After Islet Transplantation June 6, 2016 May 27, 2021
NCT00453817 Terminated Phase 1 Islet of Langerhans Graft Monitoring by Magnetic Resonance Imaging June 2005 June 2010
NCT00870818 Terminated N/A Protege Extension Trial - Long Term Follow Up Trial for Subjects Who Completed the Protege Study (CP-MGA031-01) February 2009 May 2011
NCT00315614 Terminated Phase 2 Islet Cell Transplantation Alone and CD34+ Donor Bone Marrow Cell Infusion in Type 1 Diabetes Mellitus December 2000 December 2010
NCT00672204 Terminated Phase 1/Phase 2 Raptiva and Sirolimus in Islet Transplantation for Type 1 Diabetes November 2007 August 2012
NCT01939834 Terminated N/A Early Feasibility Study of Adaptive Advisory/Automated (AAA) Control of Type 1 Diabetes December 2013 January 2014
NCT00639600 Terminated Phase 1/Phase 2 Transplantation of Pancreatic Islets in Patients With Type 1 Diabetes Mellitus and Functional Kidney Graft June 2008 May 2010
NCT00723411 Terminated Phase 3 A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (EU) July 2008 August 2011
NCT00920582 Terminated Phase 3 Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus September 2009 July 2012
NCT03325114 Terminated Phase 2 Safety and Efficacy of Chlorthalidone in Type 1 Diabetes June 28, 2019 June 1, 2020
NCT04650945 Terminated N/A In-hospital Diabetes Management With Flash Glucose Monitoring (isCGM) - the INDIGO Study, Part A January 4, 2021 November 16, 2022
NCT02239354 Terminated Phase 1/Phase 2 A Safety, Tolerability, and Efficacy Study of VC-01™ Combination Product in Subjects With Type I Diabetes Mellitus September 2014 December 2017
NCT04591925 Terminated N/A SteadiSet™ Pilot Study (SteP Study) February 5, 2021 November 2, 2021
NCT03785275 Terminated Beta Cell Imaging in T1D Patients With a Different Glycemic Control December 6, 2017 November 9, 2020
NCT04630925 Terminated N/A In-hospital Diabetes Management With Flash Glucose Monitoring (isCGM) - the INDIGO Study, Part B January 4, 2021 November 16, 2022
NCT01603121 Terminated Phase 1/Phase 2 Lisofylline as Continuous Subcutaneous and Intravenous Administration in Subjects With Type 1 Diabetes Mellitus February 2012 May 2013
NCT02605564 Terminated N/A Effects of Gluten Free Diet on Type 1 Diabetes Mellitus in Children January 19, 2016 August 2, 2022
NCT01189422 Terminated Phase 1 Subcutaneous Administration of Teplizumab in Adults With Type 1 Diabetes August 2010 February 2011
NCT02093221 Terminated Phase 2 Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus March 2014 June 2017
NCT03260868 Terminated Phase 4 Evaluation of Virtual Versus Traditional Study Conducted in a Group Pilot Study in Adult Patients With Type 1 Diabetes Mellitus (eStudy) September 19, 2017 November 22, 2018
NCT02057211 Terminated Phase 2 Mesenchymal Stem Cells to Intervene in the Development of Type 1 Diabetes: a Blinded Randomized Study April 2014 November 2017
NCT00437398 Terminated Phase 1/Phase 2 Islet Transplantation for Type 1 Diabetes Mellitus July 2006 January 2012
NCT01767831 Terminated Evaluation of a Simulation-Based Educational Tool for Personalized Feedback in Insulin Therapy Management March 2013 August 2013
NCT01201928 Terminated Pulmonary Function Substudy for Subjects Enrolled in Studies MKC-TI-161, MKC-TI-162 or MKC-TI-166 October 2010 March 2012
NCT00995540 Terminated Phase 2 Tolerability, Safety, and Efficacy Study of INGAP Peptide to Treat Type 1 Diabetes Mellitus in Adults November 2009 December 2011
NCT00751842 Terminated Phase 3 A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT September 2008 July 2012
NCT00428207 Terminated N/A Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Therapy February 2007 August 2008
NCT01035801 Terminated Phase 1 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Insulin (IN-105) in Type 1 Diabetes Patients August 21, 2010 March 12, 2011
NCT03547427 Terminated N/A Glucagon Counterregulation in Type 1 Diabetes May 20, 2018 March 11, 2019
NCT03217175 Terminated N/A Efficacy of Glucagon In the Prevention of Hypoglycemia During Mild Exercise August 18, 2017 March 9, 2018
NCT02044848 Terminated Phase 2 Study of Secukinumab in Patients With Newly-diagnosed Type 1 Diabetes Mellitus February 2014 September 2014
NCT01947036 Terminated T and B Cell Responses in Autoimmune Diseases January 2014 October 2015
NCT03838783 Unknown status Phase 4 Flexible Insulin Therapy Untethered Insulin Regimen in Avidly Exercising Patients With Type 1 Diabetes: FIT Untethered May 15, 2018 June 30, 2019
NCT01899872 Unknown status N/A Effect of Acute Exercise on Endothelial Function in Patients With Type 1 Diabetes. December 2011 December 2013
NCT00703599 Unknown status Phase 1/Phase 2 Safety and Efficacy of Autologous Adipose-Derived Stem Cell Transplantation in Patients With Type 1 Diabetes November 2007 December 2009
NCT03963219 Unknown status N/A Clinical Assessment of a Novel Advanced Bolus Calculator for Type 1 Diabetes 5 August 22, 2019 June 30, 2021
NCT02003274 Unknown status N/A Mixed Meal Test in Type 1 Diabetes on Insulin Pump Therapy: Optimization of Artificial Pancreas October 2013 October 31, 2017
NCT03011008 Unknown status Phase 4 Liraglutide as Additional Treatment to Insulin in Patients With Autoimmune Diabetes Mellitus January 2017 June 2021
NCT02023489 Unknown status N/A Lipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor Mutations July 2013 July 2018
NCT00889668 Unknown status Phase 1/Phase 2 Evaluation of the Performance and Use of Non-Invasive Glucose Monitoring Device May 2009 October 2012
NCT03066284 Unknown status A Qualitative Study on CSII in Children and Adolescents Having Type 1 Diabetes March 14, 2016 March 13, 2019
NCT03069196 Unknown status Prevalence and Incidence of Complications of Type One Diabetes in pUne at a Tertiary Care centRE June 10, 2016 June 30, 2021
NCT04926298 Unknown status Glycemic Control Before, During and After the 2016 Paris Marathon August 15, 2020 July 1, 2021
NCT03682250 Unknown status Electrocardiographic Modifications and Spontaneous Hypoglycemic Episodes in Type 1 Diabetes September 17, 2018 August 31, 2022
NCT03682640 Unknown status Phase 2 Azithromycin Insulin Diet Intervention Trial in Type 1 Diabetes September 2018 December 31, 2021
NCT03721991 Unknown status N/A GABA Treatment in Subjects With Type 1 Diabetes October 10, 2018 July 1, 2019
NCT04129424 Unknown status N/A Preliminary Exploration on the Operational Standards of Insulin Pump Installation in Diabetes Clinic in China December 1, 2019 December 1, 2020
NCT01143168 Unknown status Phase 1 Stem Cell Therapy for Type 1 Diabetes Mellitus August 2010 December 2011
NCT00433758 Unknown status N/A Evaluation of the GlucoTrack, Non-Invasive Glucose Monitoring Device December 2006 December 2008
NCT04135248 Unknown status A Randomized Control Trial in People With Type 1 Diabetes Who Will Fast Ramadan: Does Insulin Timing and Dose Matter? April 18, 2019 April 17, 2020
NCT00173641 Unknown status The Role of Regulatory T Cell in Patients With Type 1 Diabetes Mellitus September 2005 August 2006
NCT05022875 Unknown status N/A Effectiveness of The Health Care CEO App for T1D April 23, 2021 July 31, 2022
NCT02306005 Unknown status Insulin Therapy and Lipoproteins' Profile in Type 1 Diabetes. November 2014 January 2023
NCT04177303 Unknown status Phase 3 Incretin Hormones in Type 1 Diabetes Mellitus;Effect of Metformin Treatment November 29, 2019 November 29, 2022
NCT01374854 Unknown status Phase 1/Phase 2 Umbilical Mesenchymal Stem Cells and Mononuclear Cells Infusion in Type 1 Diabetes Mellitus January 2009 December 2014
NCT01382459 Unknown status Constructed Intervention by Home and School Diabetes Nurse Visits on Diabetic Control of Children With Type I Diabetes July 2011
NCT03794934 Unknown status N/A Structured Education Based on New Glucose Management Devices in Patients With Type 1 Diabetes Mellitus February 26, 2019 December 31, 2020
NCT01406496 Unknown status N/A Best Timing of Insulin Bolus Before Meals of Different Contents August 2011 December 2013
NCT04329871 Unknown status Medtronic 670G Insulin Pump and the Impact on Glycemic Control, Quality of Life, and Compliance March 24, 2020 March 23, 2021
NCT03349489 Unknown status N/A Insulin-based Strategies to Prevent Hypoglycemia During Exercise May 18, 2018 January 2019
NCT00678990 Unknown status N/A Heparinized Islets in Clinical Islet Transplantation January 2019 December 2019
NCT05144802 Unknown status N/A Accuracy of Dexcom G6® and FreeStyle Libre® Sensors in Standardized Hypoxemia Conditions May 16, 2022 November 15, 2022
NCT04414579 Unknown status Phase 4 The Efficacy and Safety of Faster Insulin Aspart (Fiasp®) Compared to Conventional Insulin Aspart (NovoLog®) as Correction Bolus March 27, 2019 March 2021
NCT01496339 Unknown status Phase 1/Phase 2 Human Menstrual Blood-derived Mesenchymal Stem Cells Transplantation in Treating Type 1 Diabetic Patients January 2012 May 2014
NCT01525784 Unknown status Affect of RT-CGMS as Part of Clinical Care in Type 1 Diabetes Mellitus Patients February 2012 June 2014
NCT03473704 Unknown status N/A Telematic Program for the Treatment of Depression in Type 1 Diabetes January 19, 2017 October 1, 2020
NCT00646724 Unknown status Phase 1/Phase 2 Cotransplantation of Islet and Mesenchymal Stem Cell in Type 1 Diabetic Patients January 2008 January 2014
NCT00472875 Unknown status Phase 4 Do Sulphonylureas Preserve Cortical Function During Hypoglycaemia? May 2007
NCT03484741 Unknown status Phase 1/Phase 2 Mesenchymal Stem Cell Therapy for Type 1 Diabetes Mellitus Patients April 1, 2017 November 2018
NCT00145353 Unknown status Phase 4 Insulin NovoRapid Versus Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose November 2004 June 2006
NCT03505268 Unknown status N/A The Impact of Telehealthcare Intervention on Glycemic Control in Children and Adolescents With Type 1 Diabetes May 1, 2018 May 3, 2019
NCT02725502 Unknown status N/A Incretin Axis in Type 1 Diabetes Mellitus July 2013 May 2016
NCT03513874 Unknown status Phase 4 Metformin Plus Insulin on Non-obese Autoimmune Diabetes August 1, 2017 April 1, 2021
NCT02745808 Unknown status Phase 1 Injectable Collagen Scaffold™ Combined With HUC-MSCs for the Improvement of Erectile Function in Men With Diabetes September 2015 December 2020
NCT03547440 Unknown status T1DM Clinical Onset and Progression in Paediatric Population March 18, 2015 September 18, 2018
NCT03554590 Unknown status N/A DM1, Effects of Carbo-Counting on Glycemic Control December 2016 January 2020
NCT04721509 Unknown status N/A Effect of Smartphone Based Telemedicine and Education in Patients With Type 1 Diabetes Mellitus February 2021 September 2022
NCT03936634 Unknown status An Innovative Approach Towards Understanding and Arresting Type 1 Diabetes (INNODIA) November 14, 2016 October 31, 2022
NCT02893306 Unknown status Phase 2 MSC Administration for the Management of Type 1 Diabetic Patients March 2012 March 2017
NCT03590262 Unknown status Phase 4 Effect of Metformin as add-on Therapy on Glycemic Control and Other Outcomes in Type 1 Diabetes January 1, 2018 September 30, 2019
NCT04754919 Unknown status N/A The Diabetes Transition Study for Young People Aged Between 16-20 Years of Age. December 1, 2018 January 2022
NCT00790257 Withdrawn Phase 1 Safety and Efficacy Study of Encapsulated Human Islets Allotransplantation to Treat Type 1 Diabetes November 2008 September 2015
NCT03774069 Withdrawn N/A The Advisor Pro Direct Study December 1, 2020 December 1, 2023
NCT03466398 Withdrawn N/A Effects of a Remote Patient Monitoring Protocol on Glycemic Control in Adolescents With Type 1 Diabetes April 11, 2018 March 5, 2020
NCT02256293 Withdrawn Phase 1/Phase 2 Acceptability and Feasibility of an ACT-Based Group to Improve Diabetes Self-Management January 2015
NCT02206568 Withdrawn Phase 1 Pharmacokinetics of Ultra-Rapid-Acting Insulin Lispro (URAL) in Type 1 Diabetes Mellitus June 2014 September 2014
NCT02635243 Withdrawn Phase 1 A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SAR438544 in Comparison to Glucagon in Type 1 Diabetes Mellitus Patients Under Induced Hypoglycemia April 2016 November 2016
NCT01045005 Withdrawn N/A Doppler Ultrasound Investigation of Microcirculations January 2006 July 2010
NCT02579148 Withdrawn Phase 1 Collagen Scaffolds Loaded With HUCMSCs for the Improvement of Erectile Function in Men With Diabetes September 2015 April 2017
NCT00971503 Withdrawn Phase 2 Safety and Efficacy of Arterial Delivery of Autologous Bone Marrow Cells in the Treatment of Insulin-Dependent Diabetes February 2011 February 2012
NCT00850161 Withdrawn Phase 2 Intranasal Insulin and Its Effect on Postprandial Metabolism in Comparison to Subcutaneous Insulin July 2009 September 2010
NCT00450489 Withdrawn Assessment of Quality of Life and Satisfaction With Medical Care of Pediatric Type 1 Diabetes Mellitus Patients June 2008 December 2009
NCT05272059 Withdrawn Phase 1 Multiple Ascending Dose Study of MHS552 in Adults With Type 1 Diabetes Mellitus September 1, 2023 April 14, 2025
NCT02109315 Withdrawn Phase 1 Vitamin C and Liraglutide Effects on Hypoglycemia-induced Oxidative Stress, Inflammation and Endothelial Dysfunction in Type 1 Diabetes. May 2014 May 2015
NCT00784966 Withdrawn Phase 1/Phase 2 Islet After Kidney Transplant for Type 1 Diabetes August 2011 September 2017
NCT01492062 Withdrawn N/A A Study to Evaluate a Multiple Model Probabilistic Predictive Controller (MMPPC) for Closed Loop Insulin Delivery February 2011 November 2013
NCT02518022 Withdrawn N/A How to be Safe With Alcoholic Drinks in Diabetes September 2015 June 2016
NCT03335501 Withdrawn Phase 2 Comparison of the Efficacy of Rapid-acting Aspart and Faster Acting Aspart Within the Context of Single-hormone Closed-loop Strategy at Regulating Postprandial Glucose Levels April 1, 2018 December 31, 2018
NCT04711226 Withdrawn Phase 2 Safety, Tolerability and Efficacy of Immunomodulation With AT-1501 in Islet Cell Transplantation February 19, 2021 June 2026
Disase is a (Disease Ontology)
DOID:9351
Cross Reference ID (Disease Ontology)
GARD:10268
Cross Reference ID (Disease Ontology)
ICD10CM:E10
Cross Reference ID (Disease Ontology)
KEGG:04940
Cross Reference ID (Disease Ontology)
MESH:D003922
Cross Reference ID (Disease Ontology)
MIM:222100
Cross Reference ID (Disease Ontology)
NCI:C2986
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:46635009
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0011854
Exact Synonym (Disease Ontology)
IDDM
Exact Synonym (Disease Ontology)
insulin-dependent diabetes mellitus
Exact Synonym (Disease Ontology)
type I diabetes mellitus
ICD10 preferred id (Insert disease from ICD10)
D0003660
ICD10 class code (Insert disease from ICD10)
E10